In the trimethoprim-sulfamethoxazole arm , 7 of 17 women ( 41 % ) with a trimethoprim-sulfamethoxazole-nonsusceptible isolate had a clinical cure compared with 84 % of women with a trimethoprim-sulfamethoxazole-susceptible isolate ( P < .001 ) .
